Document Detail


Impact and cost-effectiveness of respiratory syncytial virus prophylaxis for Kansas medicaid's high-risk children.
MedLine Citation:
PMID:  12444839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To determine the impact of prophylactic therapy for respiratory syncytial virus (RSV) infections on subsequent hospitalizations and related lengths of stay and costs and to estimate whether prophylactic treatment was cost-effective. DESIGN: Retrospective cohort study of the 1999-2000 RSV season. Propensity scores were used to identify an untreated comparison group to adjust for treatment selection bias. SETTING: State of Kansas Medicaid program. PARTICIPANTS: The study population included children 10 months or younger at the start of the RSV season or born during the season who either were premature or had chronic lung disease. All children were continuously enrolled in Medicaid throughout the season. MAIN OUTCOME MEASURES: Inpatient admission for RSV infections and associated lengths of stay and costs; cost-benefit analysis of drug costs per reduction in hospitalization costs. RESULTS: The RSV-preventive treatments reduced the odds of hospitalizations to 0.47, lengths of stay by 74%, and hospitalization costs by $703. Given an average drug cost of $4687, the cost-benefit ratio was 6.67. CONCLUSIONS: Despite the demonstrated efficacy of intravenous RSV immune globulin and palivizumab in clinical trials, use of these agents in actual practice has not generated expected outcomes in the Kansas Medicaid program. Although their use generated reductions in all 3 hospital-related outcomes, their costs overwhelmed these benefits.
Authors:
Theresa I Shireman; Karen S Braman
Related Documents :
19744519 - Excess mortality, length of stay and cost attributable to candidaemia.
23558149 - How emergency physicians use biomarkers: insights from a qualitative assessment of scri...
18086519 - The cost of moderate and severe copd exacerbations to the canadian healthcare system.
3184369 - The cost of hospitalization for firearm injuries.
11221819 - A longitudinal study of the effects of graduate medical education on hospital operating...
17176969 - Economic profiling of physician specialists: use of outlier treatment and episode attri...
7574319 - A 5-year audit of outcome of apicectomies carried out in a district general hospital.
23795379 - Part a to part b rebilling: understanding the rules in a changing environment.
500069 - Using financial ratio analysis to compare hospitals' performance.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of pediatrics & adolescent medicine     Volume:  156     ISSN:  1072-4710     ISO Abbreviation:  Arch Pediatr Adolesc Med     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-26     Completed Date:  2002-12-31     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9422751     Medline TA:  Arch Pediatr Adolesc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1251-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Pharmacy Practice, University of Kansas School of Pharmacy, 1251 Wescoe Hall Dr, Lawrence, KS 66045-7582, USA. shireman@ukans.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost-Benefit Analysis*
Female
Hospitalization / economics*
Humans
Infant
Kansas
Length of Stay
Male
Medicaid
Respiratory Syncytial Virus Infections* / economics,  prevention & control
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Jaundice noted in the first 24 hours after birth in a managed care organization.
Next Document:  Are we ready for universal school-based asthma screening?: An outcomes evaluation.